SCA practice case · Video consultation

“I don’t want to put steroids on my baby — won’t they thin her skin?”

Video consultation Child patient Someone else speaking Typical Children & young peopleLong-term conditions & cancer

The candidate brief

This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.

Patient
Anaya Sandhu · 2 years · female
Setting
Video consultation — a flaring atopic eczema (mother present).
Past history
  • Atopic eczema
Medication
  • Topical corticosteroid (issued, not used)
  • Emollient
Allergies
None recorded
Recent notes
Current flare of eczema. Steroid issued previously; mother declined to use it.
Reason for contact
Mother booked: "Her eczema is really bad again and none of us are sleeping."

Practise this case

The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.

What this case tests

Show the learning points (spoiler: read after you have practised)
An atopic eczema flare with topical-steroid phobia is, above all, an adherence and trust problem. Assess the flare and its impact — extent, itch and especially sleep disturbance (a key severity/family-impact marker) — and check for infection (bacterial weeping/golden crusting; eczema herpeticum, with clustered punched-out vesicles, rapid worsening or an unwell child, which is urgent). Steroid phobia is extremely common and drives under-treatment, so do not dismiss it: validate it as understandable given conflicting online information, then correct it with accurate facts — topical steroids used correctly (potency matched to site and severity, short bursts to control flares) are safe and effective; skin thinning is associated with prolonged use of potent steroids on inappropriate sites rather than appropriate short courses; and under-treating eczema from steroid fear prolongs the child’s itch, sleeplessness, infection risk and suffering, so the fear itself causes harm. Establish emollients as the cornerstone (generous, frequent, used as a soap substitute, continued even when clear, prescribed in large quantities — children commonly need 250–500 g a week, NICE CG57) and explain correct steroid use (NICE CG57 potency by site: mild for face and neck, moderate or potent for only 7–14 days in axillae and groin; once or twice daily, NICE TA81) with the fingertip-unit guide (one FTU covers two adult hands, BAD 2024), applied to active eczema only, then stepped down. Address triggers and scratch management, recognise and treat infection (bacterial: NICE NG190, antibiotics only if needed; eczema herpeticum needs immediate systemic aciclovir and same-day referral, with face-to-face assessment of any suspected infection), and know when to escalate to dermatology, providing a written step-up/step-down plan. The hidden agenda is a protective fear born of wanting to keep the child safe, with distress at the family’s sleeplessness and helplessness beneath; respect and answer the fear rather than overriding it, build trust, and give a clear regimen she believes in — turning her into a confident treater, because adherence is the whole game in eczema.

The guidance behind it

Similar SCA cases

Browse all 359 cases by experience group →

gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.